No Data
No Data
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
Express News | Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $6.5
Atossa Therapeutics Analyst Ratings
Atossa Therapeutics Announces Support of Final Rule From FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer
Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Atos Cuts Outlook on Softer Market as Clients Await Outcome of Rescue Plan -- Update